170 related articles for article (PubMed ID: 17912239)
21. [Correlation of MUC1 expression to adhesion of breast cancer cell line MDA-MB-231].
Lu L; Deng HY; Fan WK
Ai Zheng; 2004 Nov; 23(11):1294-6. PubMed ID: 15522176
[TBL] [Abstract][Full Text] [Related]
22. Expression of mucin antigens in human cancers and its relationship with malignancy potential.
Yonezawa S; Sato E
Pathol Int; 1997 Dec; 47(12):813-30. PubMed ID: 9503463
[TBL] [Abstract][Full Text] [Related]
23. The expression of several types of mucin is related to the biological behavior of pancreatic neoplasms.
Yonezawa S; Nakamura A; Horinouchi M; Sato E
J Hepatobiliary Pancreat Surg; 2002; 9(3):328-41. PubMed ID: 12353144
[TBL] [Abstract][Full Text] [Related]
24. The effect of adenovirus expressing wild-type p53 on 5-fluorouracil chemosensitivity is related to p53 status in pancreatic cancer cell lines.
Eisold S; Linnebacher M; Ryschich E; Antolovic D; Hinz U; Klar E; Schmidt J
World J Gastroenterol; 2004 Dec; 10(24):3583-9. PubMed ID: 15534911
[TBL] [Abstract][Full Text] [Related]
25. Biphasic effect of cell surface sialic acids on pancreatic cancer cell adhesiveness.
Sawada T; Ho JJ; Sagabe T; Yoon WH; Chung YS; Sowa M; Kim YS
Biochem Biophys Res Commun; 1993 Sep; 195(2):1096-103. PubMed ID: 8373388
[TBL] [Abstract][Full Text] [Related]
26. Benzyl-alpha-GalNAc inhibits sialylation of O-glycosidic sugar chains on CD44 and enhances experimental metastatic capacity in B16BL6 melanoma cells.
Nakano T; Matsui T; Ota T
Anticancer Res; 1996; 16(6B):3577-84. PubMed ID: 9042224
[TBL] [Abstract][Full Text] [Related]
27. [Human mucin 1 promoter drives human sodium/iodide symporter gene targeting expression in pancreatic carcinoma cells].
Zhou QB; Chen RF; Li ZH; Pan QH; Zhou JJ; Tang QB; Chen JS
Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(39):2780-4. PubMed ID: 18167272
[TBL] [Abstract][Full Text] [Related]
28. Effect of glycosylation of a synthetic MUC1 mucin-core-related peptide on recognition by anti-mucin antibodies.
Spencer DI; Price MR; Tendler SJ; De Matteis CI; Stadie T; Hanisch FG
Cancer Lett; 1996 Feb; 100(1-2):11-5. PubMed ID: 8620429
[TBL] [Abstract][Full Text] [Related]
29. Amelioration of cancer stem cells in macrophage colony stimulating factor-expressing U87MG-human glioblastoma upon 5-fluorouracil therapy.
Chockalingam S; Ghosh SS
PLoS One; 2013; 8(12):e83877. PubMed ID: 24391839
[TBL] [Abstract][Full Text] [Related]
30. Enhancement of metastatic properties of pancreatic cancer cells by MUC1 gene encoding an anti-adhesion molecule.
Satoh S; Hinoda Y; Hayashi T; Burdick MD; Imai K; Hollingsworth MA
Int J Cancer; 2000 Nov; 88(4):507-18. PubMed ID: 11058865
[TBL] [Abstract][Full Text] [Related]
31. Apical secretion and sialylation of soluble dipeptidyl peptidase IV are two related events.
Slimane TA; Lenoir C; Sapin C; Maurice M; Trugnan G
Exp Cell Res; 2000 Jul; 258(1):184-94. PubMed ID: 10912800
[TBL] [Abstract][Full Text] [Related]
32. Drug efflux transporter multidrug resistance-associated protein 5 affects sensitivity of pancreatic cancer cell lines to the nucleoside anticancer drug 5-fluorouracil.
Nambaru PK; Hübner T; Köck K; Mews S; Grube M; Payen L; Guitton J; Sendler M; Jedlitschky G; Rimmbach C; Rosskopf D; Kowalczyk DW; Kroemer HK; Weiss FU; Mayerle J; Lerch MM; Ritter CA
Drug Metab Dispos; 2011 Jan; 39(1):132-9. PubMed ID: 20930123
[TBL] [Abstract][Full Text] [Related]
33. GalNAc-alpha -O-benzyl inhibits sialylation of de Novo synthesized apical but not basolateral sialoglycoproteins and blocks lysosomal enzyme processing in a post-trans-Golgi network compartment.
Ulloa F; Franci C; Real FX
J Biol Chem; 2000 Jun; 275(25):18785-93. PubMed ID: 10751388
[TBL] [Abstract][Full Text] [Related]
34. Benzyl-N-acetyl-alpha-D-galactosaminide induces a storage disease-like phenotype by perturbing the endocytic pathway.
Ulloa F; Real FX
J Biol Chem; 2003 Apr; 278(14):12374-83. PubMed ID: 12538583
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of the glycosylation and alteration in the intracellular trafficking of mucins and other glycoproteins by GalNAcalpha-O-bn in mucosal cell lines: an effect mediated through the intracellular synthesis of complex GalNAcalpha-O-bn oligosaccharides.
Gouyer V; Leteurtre E; Zanetta JP; Lesuffleur T; Delannoy P; Huet G
Front Biosci; 2001 Oct; 6():D1235-44. PubMed ID: 11578961
[TBL] [Abstract][Full Text] [Related]
36. Structure/activity studies of the anti-MUC1 monoclonal antibody C595 and synthetic MUC1 mucin-core-related peptides and glycopeptides.
Spencer DI; Missailidis S; Denton G; Murray A; Brady K; Matteis CI; Searle MS; Tendler SJ; Price MR
Biospectroscopy; 1999; 5(2):79-91. PubMed ID: 10217327
[TBL] [Abstract][Full Text] [Related]
37. Effect of MUC1 mucin, an anti-adhesion molecule, on tumor cell growth.
Makiguchi Y; Hinoda Y; Imai K
Jpn J Cancer Res; 1996 May; 87(5):505-11. PubMed ID: 8641988
[TBL] [Abstract][Full Text] [Related]
38. Oligosaccharides expressed on MUC1 produced by pancreatic and colon tumor cell lines.
Burdick MD; Harris A; Reid CJ; Iwamura T; Hollingsworth MA
J Biol Chem; 1997 Sep; 272(39):24198-202. PubMed ID: 9305871
[TBL] [Abstract][Full Text] [Related]
39. Expression of core 2 beta-1,6-N-acetylglucosaminyltransferase in a human pancreatic cancer cell line results in altered expression of MUC1 tumor-associated epitopes.
Beum PV; Singh J; Burdick M; Hollingsworth MA; Cheng PW
J Biol Chem; 1999 Aug; 274(35):24641-8. PubMed ID: 10455130
[TBL] [Abstract][Full Text] [Related]
40. A MUC1 tandem repeat reporter protein produced in CHO-K1 cells has sialylated core 1 O-glycans and becomes more densely glycosylated if coexpressed with polypeptide-GalNAc-T4 transferase.
Olson FJ; Bäckström M; Karlsson H; Burchell J; Hansson GC
Glycobiology; 2005 Feb; 15(2):177-91. PubMed ID: 15456735
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
